50 MG Doxorubicin Hydrochloride Injection IP

Recognized as a reputed organization of in the market, we are offering 50 MG Doxorubicin Hydrochloride Injection IP, which is indicated for treatment of women with axillary lymph node involvement following resection of primary breast cancer. Provide quick relief & widely used as a component of multi-agent adjuvant chemotherapy, this 50 MG Doxorubicin Hydrochloride Injection IP is processed with advance methodology. Available in an amount of packaging options, offered injection is properly tested at advance laboratories.